Why the study?
Does live attenuated poliovirus vaccine administered by mouth or throat swab result in virus multiplication and antibody formation in newborn infants?
Does live attenuated poliovirus vaccine administered by mouth or throat swab result in virus multiplication and antibody formation in newborn infants?
Answers are grounded in this paper and cite their sources.
This study investigated the feasibility of administering live attenuated poliovirus vaccine to newborns via oral or pharyngeal routes to bypass gastric acidity and achieve immunization.
Live attenuated poliovirus vaccine was administered to 400 newborn infants during a three-month period (October, 1959, to January, 1960). This study was designed to obtain information which might provide answers to the following questions. Would the ingestion of larger doses permit enough of the vaccine viruses regularly to pass the "acid barrier" of the stomach of newborn infants and result in regular multiplication in the intestinal tract? (Poliovirus may be destroyed below a pH of 2.5 and the gastric contents of newborns often have a pH of about 1.5.)1-3 Would it be possible to by-pass the potential handicap of high gastric acidity by swabbing the vaccine directly on the posterior pharyngeal wall? Would all three types multiply following administration of a mixture of large doses of Types 1, 2, and 3 poliovirus either by mouth or by throat as determined by virus excretion and antibody formation? Materials
No takes yet. Share an insight, caveat, or question.
Saul Krugman (1961) studied Polio (n=400). Live attenuated poliovirus vaccine was evaluated on Virus excretion and antibody formation.
Synapse has enriched 10 related papers. Consider them for comparative context: